VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EVO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EVOEvotec SE
$1.69$600M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEVOBalance Sheet

Evotec SE (EVO) Balance Sheet

23Y historyFree accessUpdated daily

The equity base has eroded by approximately 45% from $1.2B to $665.6M over ten quarters, with total debt rising to $475.9M and the debt-to-equity ratio increasing to 0.71, indicating a shift toward necessity-driven financing.

Income StatementBalance SheetCash FlowRatios

EVO Balance Sheet

Annual statement

EVO Balance Sheet

Evotec SE (EVO) balance sheet — 23-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Total Current Assets663.26M762.62M681.96M903.16M1.07B1.1B806.13M527.05M249.77M180.25M169.24M166.94M125.3M122.53M88.1M83.33M86.69M68.96M93.08M111.84M113.82M81.97M65.5M34.74M
Cash & Short-Term Investments418.48M476.19M396.8M604.11M707.31M858.5M589.67M359.22M149.88M101.58M127.86M134.96M89.92M98.14M65.64M63.78M68.54M58.36M84.1M96.13M78.72M53.52M64.15M32.9M
Cash Only299.01M418.34M306.39M510.91M400.7M699.33M517.05M310.97M109.06M67.02M83.94M44.5M48.71M45.64M39.06M17.78M21.09M32.93M55.06M37.99M78.72M53.52M4.12M1.39M
Short-Term Investments119.47M57.85M90.41M93.2M306.61M159.17M72.62M48.25M40.82M34.56M43.92M90.46M41.21M52.49M26.57M46.01M47.45M25.43M29.03M58.14M0060.03M31.51M
Accounts Receivable171.27M213.42M218.38M221.9M275.77M176.75M167.48M139.34M60.94M69.98M29.83M22.19M26.15M18.21M15.53M10.59M12.44M4.86M3.9M9.17M7.77M14.13M16.34M0
Days Sales Outstanding86.27102.87100.02103.65133.95104.39122.03113.9259.2599.1466.1863.44106.6377.3464.9748.2682.1541.5335.97101.7542.1180.433.08K-
Inventory37.71M29.3M31.12M30.89M29.82M25.79M16.62M12.07M5.66M9.02M4.3M3.13M3.11M2.36M2.44M3.56M2.82M2.42M2.14M2.39M4.78M10.5M00
Days Inventory Outstanding20.1815.416.6518.5918.8520.1816.1714.057.8418.814.8312.7518.8915.7315.8728.7533.2836.4835.5335.1539.3189.17--
Other Current Assets35.8M24.75M13.42M27.87M43.82M20.68M21.04M6.13M25.27M17.03M2.68M3.39M2.51M2.11M1.16M721K01.43M951K027.89M03.15M0
Total Non-Current Assets841.71M1.02B1.23B1.35B1.18B1.13B1.03B852.81M522.11M487.02M182.13M121.6M99.3M104.85M137.32M134.88M105.17M77.64M89.82M96.04M91.71M104.14M5.41M6.99M
Property, Plant & Equipment444.54M554.39M823.94M806.56M650.2M484.6M412.7M268.53M90.52M74.66M43.42M38.33M24.05M24.24M27.18M24.95M18.49M19.16M18.47M18.46M34.67M38.16M4.44M4.46M
Fixed Asset Turnover1.46x1.37x0.97x0.97x1.16x1.28x1.21x1.66x4.15x3.45x3.79x3.33x3.72x3.55x3.21x3.21x2.99x2.23x2.14x1.78x1.94x1.68x0.44x0.80x
Goodwill0272.25M282.85M275.63M274.82M257.57M302.67M287.27M220.79M220.18M93.23M45.65M44.81M40.14M42.34M42.2M25.98M16.56M13.29M39.04M48.91M000
Intangible Assets031.56M26.44M15.45M23.82M30.85M119.95M131.33M122.99M135.03M22.45M25.15M30.21M39.83M63.27M67.65M57.62M29.01M47.17M37.48M42.99M14.13M16.34M0
Long-Term Investments187.74M52.61M42.15M142.09M150.33M287.01M72.22M46.31M28.99M22.14M3.97M80K91K87K85K-45.93M3.09M10K427K-57.06M-20.47M-93.44M00
Other Non-Current Assets50.61M36.84M37.82M95.23M74.08M56.84M45.73M26.56M15.5M15.77M8.47M3.57M139K566K1.63M46.01M3.09M12.9M10.47M58.12M1.98M159.42M192.53K779.74K
Total Assets1.5B1.78B1.91B2.25B2.26B2.24B1.84B1.38B771.88M667.27M351.37M288.54M224.6M227.38M225.43M218.21M191.86M146.6M182.9M207.88M205.53M186.11M70.91M41.73M
Asset Turnover0.44x0.43x0.42x0.35x0.33x0.28x0.27x0.32x0.49x0.39x0.47x0.44x0.40x0.38x0.39x0.37x0.29x0.29x0.22x0.16x0.33x0.34x0.03x0.09x
Asset Growth %-69.85%-7.03%-15.09%-0.21%0.99%21.63%33.18%78.76%15.68%89.91%21.77%28.47%-1.22%0.87%3.31%13.74%30.87%-19.85%-12.02%1.14%10.43%162.46%69.94%-
Total Current Liabilities285.64M367.92M344.58M464.57M337.71M324.52M255.06M200.88M196.28M245.78M73.39M56.4M33.07M38.95M33.88M42.83M32.8M26.45M21.83M24.34M55.48M29.67M7.61M5.15M
Accounts Payable48.58M64.74M85.79M134.32M97.28M72.6M52.06M35.16M31.14M26.08M12M12.17M9.45M6.65M6.36M10.13M6.98M5.24M7.19M15.09M11.48M8.11M1.25M543.91K
Days Payables Outstanding31.6634.0245.9180.8561.4956.850.6540.9243.1554.3741.3349.5357.3744.3841.2981.9482.4178.76119.43221.5894.3768.87--
Short-Term Debt0103.64M50.8M149.1M1.56M36.14M36.72M23.27M55.07M167.76M21.41M14.21M13.36M17.22M13.22M13.17M8.58M10.27M2.58M1.3M2.59M6.04M1.05M1.25M
Deferred Revenue (Current)286.91M108.02M109.81M107.86M136.67M126.78M86.44M82.4M61.19M18.99M15.91M8.86M3.35M6.28M5.78M18.19M7.67M5.48M1.24M6.58M12.68M7.5M3.37M0
Other Current Liabilities164.27M41.18M84.21M45.83M76.54M63.93M31.68M17.17M16.74M29.44M10.23M6.91M6.91M6.67M5.36M13.13M7.26M4.99M8.74M7.06M40.21M11.67M5.28M3.03M
Current Ratio2.32x2.07x1.98x1.94x3.18x3.39x3.16x2.62x1.27x0.73x2.31x2.96x3.79x3.15x2.60x1.95x2.64x2.61x4.26x4.60x2.05x2.76x8.61x6.74x
Quick Ratio2.19x1.99x1.89x1.88x3.09x3.31x3.10x2.56x1.24x0.70x2.25x2.90x3.70x3.08x2.53x1.86x2.56x2.52x4.17x4.50x1.97x2.41x8.61x6.74x
Cash Conversion Cycle74.7984.2570.7641.3991.3167.7787.5687.0423.9563.5739.6826.6668.1548.6939.54-4.9333.03-0.74-47.93-84.69-12.95100.74--
Total Non-Current Liabilities577.67M596.72M615.39M667.99M732.36M532.96M696.2M643.51M150.73M89.75M64.04M45.04M33.15M29.46M39M28.14M26.42M8.67M11.21M12.99M12.88M7.77M1.58M543.12K
Long-Term Debt417.21M194.82M392.74M477.11M328.3M326.34M405.02M364.68M54.68M20.3M7.19M8.73M8.19M04.18M2.36M3.5M3.76M8.05M9.13M6.3M3.4M1.58M543.12K
Capital Lease Obligations307.14M149.04M0170.03M162M135.96M160.21M131.87M2.87M1.17M30K0014K01K32K132K346K700K1.83M2.13M00
Deferred Tax Liabilities104.18M79.51M14.52M18.14M18.52M17.69M73.39M78.08M21.52M23.5M115K1.54M1.58M1.25M2.1M9.9M6.66M1.98M1.46M1.6M6.45M000
Other Non-Current Liabilities27.38M19.74M20.9M-152.57M17.4M18.49M25.62M25.3M20.62M16.11M15.57M28.27M19.04M19.82M20.2M15.86M12.72M832K779K1.02M-2.82M1.51M00
Total Liabilities863.31M964.64M959.98M1.13B1.07B857.48M951.26M844.39M347M335.52M137.43M101.44M66.22M68.41M72.88M70.97M59.22M35.11M33.04M37.33M68.35M37.44M9.18M5.7M
Total Debt417.21M447.5M443.54M815.35M506.67M512.92M601.94M519.83M114.47M189.93M28.83M22.94M21.55M17.24M17.4M16.71M12.22M14.38M11.33M11.66M11.91M13.27M2.62M1.8M
Net Debt118.19M29.16M137.15M304.44M105.98M-186.41M84.9M208.86M5.41M122.91M-55.11M-21.55M-27.16M-28.4M-21.66M-1.06M-8.87M-18.54M-43.74M-26.33M-66.82M-40.25M-1.49M404.16K
Debt / Equity0.65x0.55x0.47x0.73x0.43x0.37x0.68x0.97x0.27x0.57x0.13x0.12x0.14x0.11x0.11x0.11x0.09x0.13x0.08x0.07x0.09x0.09x0.04x-
Debt / EBITDA-14.15x--17.93x4.87x4.60x5.75x4.67x1.05x3.26x0.67x0.97x10.00x-3.10x1.41x1.69x-------
Net Debt / EBITDA-4.01x--6.70x1.02x-1.67x0.81x1.87x0.05x2.11x-1.27x-0.91x-12.60x--3.86x-0.09x-1.23x-------
Interest Coverage-11.96x-7.89x-15.58x-5.87x-10.71x26.61x4.05x5.09x28.79x21.27x22.63x8.24x-2.91x-12.42x-2.32x3.83x5.47x-102.51x-89.55x-30.69x-49.32x-49.91x--
Total Equity641.66M813.36M952.52M1.12B1.19B1.38B886.41M535.47M424.88M331.75M213.94M187.09M158.38M158.97M152.55M147.25M132.64M111.49M149.86M170.55M137.18M148.67M61.06M-62.37M
Equity Growth %-96.3%-14.61%-14.95%-5.67%-13.83%55.42%65.54%26.03%28.07%55.07%14.35%18.13%-0.37%4.21%3.6%11.01%18.97%-25.61%-12.13%24.33%-7.73%143.47%197.9%-
Book Value per Share1.802.292.693.163.364.142.881.791.441.140.810.680.600.660.650.630.610.520.791.192.342.761.41-34.72
Total Shareholders' Equity641.66M813.36M952.52M1.12B1.19B1.38B886.41M535.47M424M330.75M213.03M185.5M158.38M158.97M152.55M147.25M132.16M110.87M149.86M170.55M137.18M148.67M61.06M-62.37M
Common Stock177.91M177.7M177.55M177.19M176.95M176.61M200.56M169.39M149.06M147.53M133.05M132.58M131.71M131.46M118.55M118.32M115.6M108.84M108.84M73.87M68.08M62.76M17.7K794
Retained Earnings-971.22M-775.56M-672.37M-476.29M-392.38M-216.42M-529.36M-495.22M-481.01M-566.73M-592.93M-622.31M-638.83M-631.85M-606.42M-608.89M-615.64M-618.9M-573.38M-495.09M-506.88M-474.41M-89.98M-65.14M
Treasury Stock-531K-1.55M0000000000000-1K000-99K-83K000
Accumulated OCI-35.18M-45.09M-7.35M-30.64M-37.4M-12.64M-45.91M-21.96M-27.2M-28.9M-25.15M-18.51M-23.17M-27.41M-25.5M-35.07M-26.68M-27.48M-26.84M-27.48M-65.31M000
Minority Interest00000000876K992K901K1.59M0000476K613K00-6K000

Key Metrics

Growth RegimeDecelerating
ProfitabilityWeak
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Eroding equity base from persistent losses

Equity Erosion Accelerates

Evotec's total equity has contracted by approximately 45% from $1.2B in Q1 2024 to $665.6M in Q2 2026, driven by a deepening deficit in retained earnings that now stands at -$944.5M, signaling a significant and ongoing destruction of shareholder value.

The balance sheet trajectory is clearly weakening, with the equity base shrinking in every recent quarter. This erosion is not driven by share buybacks but by the accumulation of net losses, as evidenced by the retained earnings deficit growing from -$536.7M to -$944.5M over the period. This trend suggests the company's operational model is currently consuming capital rather than generating it, placing the long-term sustainability of the balance sheet in question without a clear path to profitability.

Cash Buffer Volatile but Adequate

Despite a volatile cash position that dipped to $174.0M in Q3 2025, Evotec's current ratio of 2.33 in Q2 2026 indicates a strong short-term liquidity buffer, though the recent increase in total debt to $475.9M warrants monitoring.

The company maintains a healthy current ratio, suggesting it can cover near-term obligations. However, the cash balance has been erratic, swinging from $462.6M to $174.0M and back to $348.4M, which may reflect lumpy project payments or working capital inefficiencies rather than stable operational cash generation. The recent rise in total debt to its highest level in the dataset, concurrent with a cash burn, suggests that liquidity is being maintained partly through increased borrowing, a dynamic that cannot persist indefinitely.

Leverage Creeps Higher on Cash Burn

Total debt has increased to $475.9M in Q2 2026 from $387.9M in Q1, pushing the debt-to-equity ratio to 0.71, a notable rise from the 0.55 level maintained for several quarters, indicating a shift toward necessity-driven financing.

The D/E ratio has moved from a conservative 0.55 to 0.71 in a single quarter, driven by both a rise in debt and a decline in equity. This change appears to be a direct consequence of the company's negative free cash flow and operating losses, forcing it to rely more on external financing. While the absolute leverage level is not yet critical, the direction of travel is concerning and suggests that the balance sheet is becoming more constrained as the path to profitability remains unclear.

Asset Base Contracts with Capacity

Total assets have declined from $2.4B to $1.6B over the past ten quarters, with a sharp reduction in PPE from $918.8M to $449.8M, suggesting significant asset dispositions or write-downs that may reflect underutilized capacity.

The substantial decline in net PPE, which has been cut nearly in half, is a major driver of the shrinking asset base. This could indicate the sale of facilities, accelerated depreciation, or impairment charges related to the J.POD manufacturing platform or other infrastructure. Combined with a reduction in goodwill, the asset profile is becoming leaner, but this contraction appears to be a defensive reaction to lower revenue and utilization rather than a strategic optimization, raising questions about the future scalability of the platform.

Deferred Revenue Collapse Signals Pipeline Risk

The complete disappearance of deferred revenue from $254.7M in Q1 2026 to $0 in Q2 2026 is a critical red flag, suggesting a potential loss of prepaid contracts or a fundamental shift in the company's ability to secure advance payments for its services.

Deferred revenue is a key forward indicator for a project-based business like Evotec, representing cash collected for services not yet delivered. Its abrupt elimination to zero is highly unusual and warrants immediate investigation. This could imply the termination of a major partnership, a change in contract terms, or a failure to renew prepaid agreements. Given the company's reliance on long-term partnerships, this metric's collapse may signal a more severe deterioration in business visibility and future revenue streams than the headline numbers suggest.

EVO — Frequently Asked Questions

Quick answers to the most common questions about buying EVO stock.

What are the total assets of Evotec SE (EVO)?

As of 2025, Evotec SE (EVO) had total assets of $1.78B including $762.6M in current assets.

How much debt does Evotec SE (EVO) have?

Evotec SE (EVO) carries total debt of $447.5M, offset by $476.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Evotec SE?

Evotec SE (EVO) has total shareholders' equity (book value) of $813.4M ($2.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Evotec SE's current ratio and liquidity?

Evotec SE (EVO) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.